Migal Galilee Research Institute
1 clinical trials · Sponsor
◉ Watch Migal Galilee Research Institute
| Record | Firm | Date |
|---|---|---|
| Selective Immunotargeting of Pathogenic CD8 T Cells of Type 1 Diabetes Patients (NCT02117518) | Migal Galilee Research Institute | 2014-05-01 |
Track Migal Galilee Research Institute automatically
Every clearance here is in the API, with alerts when new ones post.